Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bacon

Showing results (561-570 of 609) with videos related to

Pageof 61
Sort By:
Journal of Viral Hepatitis|October 13, 2016
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health studyE B Tapper, B R Bacon, M P Curry, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2012
Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activityBabu G Sundar, Thomas R Bailey, Derek Dunn, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 29, 2006
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3S F Drake, E H Morgan, C E Herbison, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesisRabindranath Tripathy, Alyssa Reiboldt, Patricia A Messina, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
Journal of Medicinal Chemistry|May 23, 2000
1,3,5-Trialkyl-2,4,6-triiodobenzenes: novel X-ray contrast agents for gastrointestinal imagingK G Estep, K A Josef, E R Bacon, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Hereditary hemochromatosis in liver transplantationM I Fiel, T D Schiano, H C Bodenheimer, et al.
The New England Journal of Medicine|April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infectionBruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2008
Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinasesReddeppareddy Dandu, Allison L Zulli, Edward R Bacon, et al.
Pageof 61

Showing results (561-570 of 609) with videos related to

Sort By:
Pageof 61
Journal of Viral Hepatitis|October 13, 2016
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health studyE B Tapper, B R Bacon, M P Curry, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2012
Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activityBabu G Sundar, Thomas R Bailey, Derek Dunn, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 29, 2006
Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3S F Drake, E H Morgan, C E Herbison, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesisRabindranath Tripathy, Alyssa Reiboldt, Patricia A Messina, et al.
Hepatology (Baltimore, Md.)|June 28, 2000
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trialA M Di Bisceglie, H L Bonkovsky, S Chopra, et al.
Gastrointestinal Endoscopy|November 26, 2002
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002Sidney Cohen, Bruce R Bacon, Jesse A Berlin, et al.
Journal of Medicinal Chemistry|May 23, 2000
1,3,5-Trialkyl-2,4,6-triiodobenzenes: novel X-ray contrast agents for gastrointestinal imagingK G Estep, K A Josef, E R Bacon, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Hereditary hemochromatosis in liver transplantationM I Fiel, T D Schiano, H C Bodenheimer, et al.
The New England Journal of Medicine|April 1, 2011
Boceprevir for previously treated chronic HCV genotype 1 infectionBruce R Bacon, Stuart C Gordon, Eric Lawitz, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2008
Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinasesReddeppareddy Dandu, Allison L Zulli, Edward R Bacon, et al.
Pageof 61